期刊文献+

心力衰竭家兔钙调蛋白依赖性蛋白激酶Ⅱ异常的研究 被引量:1

Abnormal Caleium/calmodulin-dependent protein kinase-Ⅱ in heart failure rabbit
下载PDF
导出
摘要 目的探讨家兔慢性心力衰竭(心衰)时心肌钙调蛋白依赖性蛋白激酶Ⅱ(CaMKⅡ)蛋白表达及活性改变的意义。方法14只家兔随机分为2组,假手术组和心衰组各7只,通过超容量负荷联合压力负荷建立家兔心衰模型,于术后7周观察左心室结构、血流动力学的变化及CaMKⅡ的表达和活性的改变。结果与假手术组比,心衰组左心室重量指数[(1.3±0.1)g/kg比3.6±0.1)g/kg]、左室舒张末径[(13.3±1.8)him比(21.4±2.5)mm]、左室后壁厚度[(2.0±0.2)mm比(2.9±0.8)min]、左心室舒张末压[(01.5±O.5)mm Hg比(23.0±2.4)mmHg]明显升高(P〈0.05),左心室缩短率[(37.8±3.6)%比(17.4±3.1)%]及左室射血分数[(71.9±4.6)%比(38.5±6.1)%]明显降低(P〈O.05);CaMKII蛋白表达(1.45±0.13)及活性[(3.54±0.17)pmol·min-1·μg-1]显著高于假手术组[(O.89±0.05),(2.18±0.13)pmol·min-1·μg-1](P〈0.05)。结论心肌CaMKⅡ蛋白表达及活性增加可能是导致心力衰竭的发生因素之一。 Objective To investigate the expression and activity of Calcium/calmodulin-dependent pro- tein kinase- Ⅱ (CaMKⅡ ) in heart failure rabbit. Methods 14 rabbits were divided into two groups : 6 rabbits with heart failure induced by volume overload plus pressure overload, 7 sham operated rabbits. 7 weeks later, left ven- tricular function, hemodynmnic parameters, expression and activity of CaMK Ⅱ were observed. Results Compared with the sham operated rabbits, LVMI [ ( 1.3 ±0.1 )g/kg vs ( 3.6 ±0.1 )g/kg ], LVEDD [ ( 13.3 ± 1.8 )ram vs ( 21.4 ± 2.5)mm], LVPW [(2.0±0.2)mm vs (2.9±0.8)mm and LVEDP [(-1.5±0.5)mm Hg vs (23.0±2.4)mm Hg] in heart failure rabbits were significantly increased(P〈0.05), but their left ventricular shorten fraction [ (37.8±3.6)% vs (17.4±3.1)% ] and ejection fraction [(71.9±4.6)% vs (38.5±6.1)% ] were decreased(P〈0.05). Expression (1.45±0.13 vs 0.89±0.05) and activity[(3.54±0.17)pmol·min-1·μg-1 vs (2.18±0.13)pmol·min-1·μg-1] of CaMK 11 in heart failure rabbits were remarkably higher than sham operated rabbits (P〈0.05). Conclusion Upregulation of expression and activity of CaMK Ⅱ might contribute to risk factors of dysfunction in failing hearts.
出处 《中国心血管病研究》 CAS 2010年第2期141-144,共4页 Chinese Journal of Cardiovascular Research
关键词 心力衰竭 充血性 钙(2+)-钙调蛋白依赖性蛋白激酶 Heart failure, congestive Ca(2+)- calmodulin dependent protein kinase
  • 相关文献

参考文献11

  • 1吴彦.心力衰竭最新研究进展[J].中国心血管病研究,2003,1(3):169-171. 被引量:21
  • 2Hund TJ, Rudy Y. A role for calcium/calmodulin-dependent protein kinase Ⅱ in cardiac disease and arrhythmia. Handb Exp Pharmacol, 2006,171 : 201-220.
  • 3邹操,刘志华,赵彩明,蒋彬,宋建平,杨向军,蒋廷波,杨俊华,蒋文平.超容量负荷联合压力负荷制备家兔心衰模型的可行性探讨[J].实验动物与比较医学,2005,25(4):211-214. 被引量:31
  • 4Maier LS,Bers DM. Role of Ca^2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart.Cardiovasc Res, 2007,73 : 631-640.
  • 5柯俊,张存泰,马业新.CaMKⅡ与心肌肥厚[J].中国心血管病研究,2006,4(12):936-938. 被引量:2
  • 6Kashiwase K, Higuchi Y, Hirotani S, et al. CaMK Ⅱ activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy. Biochem Biophys Res Commun,2005,327:136-142.
  • 7Ramirez MT,Zhao XL,Sehulman H,et al. The nuclear delta B isoform of Ca^2+/calmodulin-dependent protein kinase Ⅱ regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chem, 1997,272 : 31203-31208.
  • 8信文君,黎明涛,杨红卫,张红梅,胡能伟,胡晓东,张彤,刘先国.磷酸化钙/钙调蛋白依赖性蛋白激酶Ⅱ在大鼠脊髓背角C-纤维诱发电位长时程增强的诱导和维持中的作用[J].生理学报,2004,56(1):83-88. 被引量:6
  • 9Zhang T, Maier LS, Dalton ND, et al. The dehaC isoform of CaMK Ⅱ is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res, 2003,92 : 912-919.
  • 10Kawai T,Nomura F,Hoshino K,et al. Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity. Oncogene, 1999,18 : 3471-3480.

二级参考文献36

  • 1[1]Liu XG, Sandkuhler J. Long-term potentiation of C-fiberevoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-D-aspartic acid receptor blockage.Neurosci Lett 1995;191: 43-46.
  • 2[2]Liu X, Sandkuhler J. Characterization of long-term potentiation of C-fiber-evoked potentials in spinal dorsal horn of adult rat: essential role of NK1 and NK2 receptors. J Neurophysiol 1997;78: 1973-1982.
  • 3[3]Sandkuhler J. Learning and memory in pain pathways. Pain 2000;88:113-118.
  • 4[4]Soderling TR, Chang B, Brickey D. Cellular signaling through multifunctional Ca2+/calmodulin-dependent protein kinase Ⅱ. J Biol Chem 2001;276:3719-3722.
  • 5[5]Fang L, Wu J, Lin Q, Willis WD. Calcium-calmodulindependent protein kinase Ⅱ contributes to spinal cord central sensitization. J Neurosci 2002;22:4196-4204.
  • 6[6]Walikonis RS, Jensen ON, Mann M, Provance DW, Jr.,Mercer JA, Kennedy MB. Ⅱdentification of proteins in the postsynaptic density fraction by mass spectrometry. J Neurosci 2000;20:4069-4080.
  • 7[7]Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A,Terasawa M, Hidaka H. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase Ⅱ. J Biol Chem 1990;265:4315-4320.
  • 8[8]Lisman J, Schulman H, Cline H. The molecular basis of CaMK Ⅱ function in synaptic and behavioural memory. Nat Rev Neurosci 2002;3:175-190.
  • 9[9]Wang Z, Song D, Berger TW. Contribution of NMDA receptor channels to the expression of LTP in the hippocampal dentate gyrus. Hippocampus 2002;12:680-688.
  • 10[10]Otmakhov N, Gfiffith LC, Lisman JE. Postsynaptic inhibitors of calcium/calmodulin-dependent protein kinase type Ⅱ block induction but not maintenance of pairing-induced long-term potentiation. J Neurosci 1997;17:5357-5365.

共引文献55

同被引文献9

  • 1Gray CB, Brown H. CaMK I1 delta subtypes: localization and function. Front Pharmaco, 2014,11 : 5-15.
  • 2Anderson ME, Braun AP, Wu Y, et al. KN-93, an inhibitor of muhifunctional Ca2+/calmodulin-dependent protein kinase, de- creases early afterdepolarizations in rabbit heart. Pharmaeol Exp Ther, 1998,287:996-1006.
  • 3Backs J, Backs T, Neef S, et al. The delta isoform of CaM ki- nase I1 is required for pathological cardiac hypertrophy and re- modeling after pressure overload. Proc Natl Acad Sci USA, 2009,106 : 2342-2347.
  • 4Peng W, Zhang Y, Zheng M, et al. Cardioprotection by CaMK 1I -deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Cire Res, 2010,106 : 102-110.
  • 5Awad S, Kunhi M, Little GH, et al. Nuclear CaMK II enhances histone H3 phosphorylation and remodels ehromatin during car- diac hypertrophy. Nucleic Acids Res, 2013,41 : 7656-7672.
  • 6Kashiwase K, Higuchi Y, Hirotani S, et al. CaMK II activates ASKI and NF-kappaB to induce cardiomyocyte hypertrophy. Biochem Biophys Res Commun, 2005,327 : 136-142.
  • 7Westenbrink BD, Ling H, Divakaruni AS, et al. Mitochondrial Reprogramming Induced by CaMKII Mediates Hypertrophy De- compensation. Cire Res, 2015,116 : e28-39.
  • 8Sossalla S, Fluschnik N, Schotola H, et al. Inhibition of elevat- ed Ca2+/calmodulin-dependent protein kinase II improves con- tractility in human failing myocardium. Circ Res,2010,107: 1150-1161.
  • 9Neef S, Sag CM, Daut M, et al. While systolic cardiomyocyte function is preserved, diastolic myocyte function and recovery from acidosis are impaired in CaMK I1 -KO mice. Mol Cell Cardiol, 2013,59 : 107-116.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部